Home > Healthcare > Pharmaceuticals > Drug Delivery > Injectable Drug Delivery Market

Injectable Drug Delivery Market Share

Report ID: GMI9720
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Injectable Drug Delivery Market Share

The global market for injectable drug delivery is highly competitive, driven by technological innovation, increased emphasis on personalized and preventive healthcare, and a rising global aging population. With the increasing prevalence of chronic diseases and the growing demand for targeted and efficient drug delivery systems, numerous players are vying for market share by offering innovative solutions tailored to diverse therapeutic needs. Moreover, technological advancements in drug delivery devices, such as auto-injectors, prefilled syringes, and wearable injectors, have intensified competition by offering enhanced convenience, safety, and patient compliance. Furthermore, regulatory requirements and quality standards play a significant role in shaping the competitive scenario, with adherence to stringent guidelines driving differentiation and market positioning among players.

Injectable Drug Delivery Market Companies

Some of the eminent market participants operating in the injectable drug delivery industry include:

A. Menarini Diagnostics s.r.l
Abbott Laboratories
ARKRAY, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Ceragem Medisys Inc.
Danaher Corporation
EKF Diagnostics
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Pfizer Inc.
PTS Diagnostics
SAKAE HOLDINGS LTD.
Sanofi
SEKISUI CHEMICAL CO., LTD.
Siemens Healthineers AG
Trinity Biotech plc

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Injectable drug delivery industry size was USD 738.4 billion in 2023 and is estimated to record 9.4% CAGR from 2024 to 2032, as it offers rapid and precise delivery of medications into the bloodstream or targeted tissues.

The conventional injection devices segment is forecasted to reach USD 507.7 billion by 2032, due to advancements in precision engineering and materials science.

The central nervous system site of administration segment in the market reached USD 319.5 billion in 2023, led by the imperative for advancing treatment efficacy and patient outcomes in neurological disorders.

U.S. injectable drug delivery industry size is forecasted to reach USD 598.9 billion by 2032, driven by a combination of technological advancements, regulatory compliance, patient safety concerns, and operational efficiency needs.